Cash and cash equivalents of $238.5 million at March 31, 2023 compared to $271.1 million at March 31, 2022 and $491.7 million at December 31, 2022. Total debt, net of cash, of $122.7 million at March 31, 2023 compared to $60.1 million at March 31, 2022 and ($175.5) million at December 31, 2022. The sequential increase in total debt, net of cash, was primarily due to an increase in cash used in operating activities, which included annual bonus payments.
During the quarter ended March 31, 2023, the Company repurchased 112,139 shares of its common stock at an average price per share of $158.70 for a total cost of $17.8 million. As of March 31, 2023, approximately $460.7 million remained available for common stock repurchases under the Company’s stock repurchase program.
First Quarter 2023 Segment Results
Corporate Finance & Restructuring
Revenues in the Corporate Finance & Restructuring segment increased $46.7 million, or 18.4%, to
$300.0 million in the quarter compared to $253.3 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $51.4 million, or 20.3%, compared to the prior year quarter. Acquisition-related revenues contributed $1.5 million in the quarter. The increase in revenues was due to higher demand for restructuring and business transformation services, which was partially offset by a decline in demand for transactions services. Adjusted Segment EBITDA of $55.0 million, or 18.3% of segment revenues, compared to $53.5 million, or 21.1% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was primarily due to higher revenues, which was partially offset by higher compensation, which includes the impact of a 13.9% increase in billable headcount, and higher SG&A expenses compared to the prior year quarter.
Forensic and Litigation Consulting
Revenues in the Forensic and Litigation Consulting segment increased $19.5 million, or 12.7%, to $173.4 million in the quarter compared to $153.9 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $22.0 million, or 14.3%, compared to the prior year quarter. The increase in revenues was primarily due to higher demand for data & analytics, investigations and health solutions services. Adjusted Segment EBITDA of $18.6 million, or 10.7% of segment revenues, compared to $17.3 million, or 11.2% of segment revenues, in the prior year quarter. The increase in Adjusted Segment EBITDA was primarily due to higher revenues, which was partially offset by an increase in compensation, which includes the impact of a 4.2% increase in billable headcount, an increase in as-needed contractor expenses and higher SG&A expenses compared to the prior year quarter.
Economic Consulting
Revenues in the Economic Consulting segment increased $3.6 million, or 2.2%, to $169.6 million in the quarter compared to $166.0 million in the prior year quarter. Excluding the estimated negative impact from FX, revenues increased $8.6 million, or 5.2%, compared to the prior year quarter. The increase in revenues was primarily due to higher demand for merger and acquisition (“M&A”)-related antitrust services and higher realization for non-M&A-related antitrust services, which was partially offset by lower demand for non-M&A-related antitrust services. Adjusted Segment EBITDA of $14.2 million, or 8.4% of segment revenues, compared to $21.2 million, or 12.8% of segment revenues, in the prior year quarter. The decrease in Adjusted Segment EBITDA was primarily due to higher compensation, which includes the impact of an 8.5% increase in billable headcount, and higher SG&A expenses compared to the prior year quarter.